Mangetsu Ebisen (Daiso) – Unlisted Krill (2023)
Class II: A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Class II recall indicates potential for temporary health effects.
This AI-generated summary is provided for general informational purposes only and is derived from publicly available recall notices. It supplements but does not replace official agency classifications or safety instructions.
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
Mangetsu Ebisen 54g UPC: 4901053011370
Brand
DAISO CALIFORNIA WAREHOUSE
Lot Codes / Batch Numbers
No code on package
Products Sold
No code on package
DAISO CALIFORNIA WAREHOUSE is recalling Mangetsu Ebisen 54g UPC: 4901053011370 due to Ingredients statement does not list krill; contains statement warns for fish(cuttlefish) and shellfish(shrimp). This is a Class I recall, indicating a high risk of serious health consequences. Based on FDA enforcement report.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
Ingredients statement does not list krill; contains statement warns for fish(cuttlefish) and shellfish(shrimp)
Recommended Action
Per FDA guidance
Consumers should stop using the product and contact the recalling firm or return it to the place of purchase.
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticeDistribution
As reported by FDA
CA, IN, NV, NJ, NY, TX, WA
Page updated: Jan 6, 2026